Pathfinder Initiates Minimally Invasive Surgical Navigation Study

Pathfinder Therapeutics, Inc. has initiated a clinical study to assess the value of Explorer^TM, its image-guided surgical platform, in minimally invasive liver resections and ablations.  Clinical sites participating in the study include: Memorial Sloan-Kettering Cancer Center, University of Pittsburgh Medical Center, Providence Portland Medical Center, and UNC-Chapel Hill.